Based on the evidence that olaparib induces NF-κB-mediated upregulation of FAS [104] and that IKKβ inhibition suppresses HR, PARylation and NHEJ [105] in AML cells, the combined inhibition of the two molecules has been tested. This evidence concerns the gene FAS and acute myeloid leukemia.